Oxidative stress and schizophrenia: recent breakthroughs from an old story
Other than the passive memory decay, Rac1 was also investigated in the active memory forgetting using retroactive interference (RI) and reversal learning and shown to have similar effects as in the passive memory decay (Shuai et al., 2010)
Testimonials are not intended to represent typical results
ONeil PM, Aroda VR, Astrup A, Kushner R, Lau DCW, Wadden TA, et al
What is already known on this topic Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a promising drug class that has shown benefits for adults with type 2 diabetes Regulatory authorities have approved several GLP-1RA drugs, and novel drugs are continually emerging, resulting in an urgent need for updated evidence synthesis of the comparative effectiveness of various GLP-1RAs What this study adds Compared with the placebo, all 15 GLP-1RAs had significant effects on glycaemic control, and tirzepatide was the most effective in reducing haemoglobin A 1c and fasting plasma glucose concentrations CagriSema induced the highest weight reduction in adults with type 2 diabetes, followed by tirzepatide and retatrutide Several GLP-1RAs resulted in a significantly higher odds ratio of discontinuation due to adverse events than placebo, raising safety concerns about gastrointestinal adverse events, especially at high doses Ethics statements Ethical approval Not required
Our telehealth platform connects you directly with licensed professionals who tailor your treatment to your unique health goals and deliver medication straight to your door
